INTRODUCTION {#sec1-1}
============

Advanced glycation end-products (AGEs) are a result of nonenzymatic reactions called Maillard reaction.\[[@ref1]\] These reactions are initiated by a nucleophilic addition between the free amino group of a protein and a carbonyl group from a reducing sugar to produce, in a matter of hours, a reversible Schiff\'s base that can rearrange within a few days to a more stable and irreversible ketoamine or Amadori product.\[[@ref2]\] This rearrangement is followed by a series of cascade reactions that include dehydration, oxidation, condensation, and cyclization to form cross-linked fluorescent and nonfluorescent AGEs.\[[@ref3][@ref4][@ref5]\] Since the formation of AGEs depends on the presence of a sugar and a protein, hyperglycemic conditions, such as those in diabetes, favor AGE formation, causing alterations in the physicochemical and physiological functions of proteins, and ultimately resulting in cell damage.\[[@ref6][@ref7]\] The important role played by AGEs in the pathogenesis of microvascular damage that includes nephropathy, retinopathy, neuropathy, and cataracts in diabetes mellitus (DM) is well recognized; similarly, the high levels of AGEs and their receptors have been detected in obese individuals.\[[@ref8]\] AGEs are also known to be involved in the development of Alzheimer\'s and other neurological diseases,\[[@ref9]\] as well as in cardiovascular diseases, including atherosclerosis,\[[@ref10]\] endothelial dysfunction, and vasorelaxation.\[[@ref11]\]

Since the formation of AGEs is characteristic of individuals with DM, where their formation and accumulation develop at an accelerated rate and correlate with the severity of the complications, and are related to cell damage due to an increase in the production of reactive oxygen species involved in the auto-oxidation of glucose and reactions of the nonenzymatic protein glycosylation pathway,\[[@ref12][@ref13][@ref14][@ref15]\] antioxidants capable of radical scavenging or metal chelation,\[[@ref16][@ref17]\] as well as metabolites able to trap dicarbonyl species or break AGEs, have the potential to limit or reduce the amount of AGEs and their related complications.\[[@ref12]\]

It has been reported that metabolites with anti-AGE and/or antioxidant activity can effectively protect against glucose-induced cytotoxicity.\[[@ref18]\] However, although numerous AGE inhibitors, including the well-known aminoguanidine, ameliorated diabetic complications in an animal model, they also caused severe side effects including gastrointestinal disturbance, anemia, and flu-like symptoms.\[[@ref19]\] Natural products represent an important option for the discovery and development of new anti-AGE pharmaceuticals; these can include metabolites with antioxidant activity since oxidative stress is involved and accelerates the formation of AGEs.\[[@ref20]\] Plants, because of the complexity of their secondary metabolism that results in a great chemical diversity of natural products, are recognized as an important source of bioactive metabolites.\[[@ref21]\] In addition, since many plants are traditionally used to treat diseases such as diabetes and others disorders associated with AGE formation, these particular species constitute a potentially important source for the search of novel secondary metabolites with anti-AGE activity.\[[@ref22]\] We wish to report herein on the results of evaluating the anti-AGEs and radical scavenging activity of the organic extracts and aqueous traditional preparations of nine plants used in Yucatecan traditional medicine to treat diabetes, hypertension, and obesity.

MATERIALS AND METHODS {#sec1-2}
=====================

Collection of plant material {#sec2-1}
----------------------------

Plant material was collected in October--November 2013 and identified by field specialist Paulino Simá-Polanco; a voucher specimen of each species was deposited in the Herbarium of Unidad de Recursos Naturales CICY under the appropriate collection number: *Brosimum alicastrum* (BAL) Swartz (P. Simá 3153), *Bunchosia swartziana* Griseb (P. Simá 3155), *Ehretia tinifolia* (L.) (P. Simá 3152), and *Manilkara zapota* (L.) P. Royen (P. Simá 3154) were collected in Mopila, a community of Yaxcabá, Yucatán, México. Plants of *Cassia fistula* (L.) (P. Simá 3158) were collected on the road from Dzitya to Chablekal, Yucatán, México, 200 m from the entrance of "Universidad de Chapingo"; fruits and inflorescences of *Cocos nucifera* (L.) (P. Simá 3166) were collected from a study site in San Crisanto, Yucatán, México; *Ocimum campechianum* Willdenow (P. Simá 3157) was collected on the road from Sierra Papacal to Chuburná Puerto, Yucatán, México, 100 m from the entrance to "Parque Científico y Tecnológico de Yucatán"; *Piper auritum* Kunth (P. Simá 3159) was collected in a private home in Baca, Yucatán, México; and *Rhizophora mangle* (L.) (P. Simá 3156) was collected in Chuburná Puerto, Yucatán, México.

Preparation of plant extracts {#sec2-2}
-----------------------------

Leaves, stems, and roots of each species (inflorescences only in the case of *C. nucifera*) were first dried for 3 days at room temperature and then for 3 days in an oven at 50°C. The plant material was ground and extracted by maceration (three times) with ethanol (400 ml/20 g of plant material), at room temperature, for 72 h. Only water from *C. nucifera* was extracted by liquid-liquid extraction with ethyl acetate in the ratio of 2:1 (v/v, three times). The plant material was eliminated by successive filtration through cheesecloth and filter paper (Whatman No. 1), and the ethanol filtrates were eliminated under reduced pressure to produce the corresponding crude extracts. For the traditional preparations, an infusion of the dry plant material commonly used in traditional medicine was prepared by adding it to boiling water (20 g/L) and allowing it to stand for 20 min. The plant material was eliminated by filtration and the resulting aqueous extract was frozen and lyophilized; in the case of *C. nucifera*, since water is traditionally used as a remedy, water from a coconut was filtered, frozen, and lyophilized to produce the corresponding crude extract of the aqueous traditional preparation. The yields of the extracts are listed in [Table 1](#T1){ref-type="table"}.

###### 
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Inhibition of anti-advanced glycation end products {#sec2-3}
--------------------------------------------------

The anti-AGE assay was carried out following the methodology previously reported by Séro *et al*.\[[@ref5]\] Briefly, the samples (1 µg to 1 mg) were incubated with D-ribose (0.5 M) and bovine serum albumin (BSA, 10 mg/ml) in a Na-phosphate buffer (50 mM pH 7.4); the solutions were incubated in black microtiter plates (96 wells) at 37°C for 24 h in a closed system before AGE fluorescence measurement. Both vesperlysines-like (λ~exc~370 nm; λ~em~440 nm) and pentosidine-like (λ~exc~335 nm; λ~em~385 nm) AGE fluorescence were measured using a microplate spectrofluorometer Infinite M200 (Tecan, Lyon, France).

To avoid quenching phenomena, the fluorescence resulting from the incubation in the same conditions of BSA (10 mg/ml) and the tested extract (1 µg to 1 mg) was subtracted from each measurement. The negative control, i.e. 100% inhibition of AGEs formation, consisted of wells with only BSA. A control, i.e. no inhibition of AGEs formation, consisted of wells with BSA (10 mg/ml) and D-ribose (0.5 M). The final volume assay was 100 µL. The percentage of AGE formation was calculated as follows for each extract concentration: AGEs (%) = (fluorescence intensity \[sample\] − fluorescence \[blank of sample\]/fluorescence intensity \[control\] − fluorescence \[blank of control\]) ×100.

Dose--effect curves were best fit with a sigmoidal dose--response equation using Sigma Plot 12.5 software (Systat Software GmbH: Erkrath, Germany), which enabled calculation of the IC~50~ values. Results were compared with those of reference products, aminoguanidine and quercetin.

Antioxidant activity by the 2, 2-Diphenyl-1-picrylhydrazyl radical scavenging method {#sec2-4}
------------------------------------------------------------------------------------

The assay was carried out following the method reported by Brand-Williams *et al*.,\[[@ref23]\] with modifications and scaled to a 96-well microplate. For the quantitative analysis, different test solutions (1 × 10^−\ 1^, 1 × 10^−2^, 1 × 10^−3^, and 1 × 10^−4^ mg/mL) of the various crude extracts were prepared and 20 µL of the test solution was combined with 180 µL of a 0.1 mM solution of 2, 2-Diphenyl-1-picrylhydrazyl (DPPH) in EtOH. The 96-well microplate was left to stand for 20 min in dark, and the absorbance was determined by reading at 540 nm in a microplate reader (ELx800-Biotek). Vitamin C (ascorbic acid) solutions were similarly prepared and used as positive control. A mixture of EtOH (20 µL) and DPPH solution (20 µL) was used as blank. The DPPH radical reduction percentages were calculated using the formula: DPPH radical reduction (%) =1 − (\[absorbance of sample/absorbance DPPH\] ×100).

The different concentrations were plotted against the decoloration percentages, and a lineal regression statistical analysis (Excel) of the resulting curve allowed the expression of the antioxidant activity of each sample in terms of its EC~50~ value. All samples were analyzed in triplicate in three different days.

Data analysis {#sec2-5}
-------------

To determine the most active samples in the antioxidant assay, statistical treatment of the data was carried out using the Sigma Plot 10.0 software, with a statistical significance between the mean differences of *P* \< 0.05 by analysis of variance with Tukey\'s *post hoc* test.

RESULTS AND DISCUSSION {#sec1-3}
======================

The anti-AGE assay comprised the simultaneous quantification of both vesperlysines-like (λ~exc~370 nm; λ~em~440 nm) and pentosidine-like (λ~exc~335 nm; λ~em~385 nm) AGEs. It has been reported that on evaluating the anti-AGE activity of extracts, semipurified fractions, or pure metabolites, samples must be tested for their anti-AGE activity against both vesperlysines and pentosidine-like AGEs, since interference between AGEs and the samples can occur.\[[@ref5]\] In this investigation, extracts were considered to be active when a decrease in the fluorescence of at least one wavelength was observed and when the IC~50~ was below than that of the natural product quercetin. Evaluation of the anti-AGE activity of the ethanol extracts and aqueous traditional preparations of nine Yucatecan medicinal plants traditionally used to treat diabetes, hypertension, and obesity showed that the root extract of *C. fistula* (CFR) presented the highest inhibition activity against vesperlysine and pentosidine-like AGEs (IC~50~ =0.1 mg/mL for both), higher even than the control aminoguanidine (IC~50~ =1.0 and 0.17 mg/mL) \[[Table 1](#T1){ref-type="table"}\]; the organic extracts from the leaves and stems of *C. fistula* (CFS), together with those of the leaves of *B. alicastrum* (BAL), stems of E. tinifolia (ETS), leaves of *P. auritum* (PAL), and leaves of *R. mangle* (RML) showed anti-AGEs activity, but only against vesperlysine-like AGEs (IC~50~ =0.50, 0.20; 0.5, 0.2; 0.35, and 0.3 mg/mL, respectively) \[[Table 1](#T1){ref-type="table"}\].

Alternatively, testing of the same group of samples for their antioxidant activity using the DPPH radical scavenging test showed a significant level of activity in the organic extracts from the stem of *E. tinifolia* (ETS) (EC~50~ =100 ± 9 µg/mL), the leaves of *M. zapota* (MZL) and roots of *M. zapota* (MZR) (EC~50~ =98 ± 10 and 107 ± 7 µg/mL, respectively), the leaves (PAL) and roots (PAR) of *P. auritum* (EC~50~ =135 ± 7 and 155 ± 7 µg/mL, respectively), and the aqueous traditional preparations of *E. tinifolia* (ETT), *M. zapota* (MZT), and *O. campechianum* (OCT) (EC~50~ =139 ± 0.7, 165 ± 7, and 150 ± 28 µg/mL, respectively) \[[Table 1](#T1){ref-type="table"}\].

It has been reported that the antioxidant effect of plant products is mainly due to the radical scavenging activity of phenolic metabolites such as flavonoids, tannins, and phenolic terpenes,\[[@ref24]\] and it has been reported that crude extracts and pure metabolites with antioxidant properties often show anti-AGE activity.\[[@ref17][@ref25]\] However, the unexpected results obtained in this study, where these two biological activities are not necessarily associated with each other, suggest that there might be other mechanisms (e.g. trapping of dicarbonyl species or AGE-breaking) involved in the anti-AGE activity of the antioxidant extracts. The root extract of *C. fistula* (CFR) exhibited the best anti-AGE activity, with results similar to those reported in the literature for bioactive plant crude extracts.\[[@ref5]\] Even though to date, there are no reports on the anti-AGE activity of *C. fistula*, a high anti-AGE activity has been reported for the flower extract of C. auriculata.\[[@ref26]\] In addition, anthraquinones isolated from the seeds of Cassia tora also exhibited a strong inhibitory activity against AGE formation,\[[@ref27]\] while phytochemical studies carried out on the roots of *C. fistula* showed the presence of rhamnetin 3-O-gentibioside,\[[@ref28]\] and the secondary metabolite composition of different parts of the plant is recognized as being phenolic antioxidants such as anthraquinones, flavonoids, and flavan-3-ol derivatives.\[[@ref29]\]

The anti-AGE and antioxidant activity detected in the organic extract from the leaf extract of *P. auritum* (PAL) coincides with reports on the literature that the strong anti-AGE activity in the hexane leaf extract of the plant, when tested in both *in vitro* and *in vivo* models, is related to its antioxidant activity.\[[@ref30]\] However, the radical scavenging activity of the leaf extract of *P. auritum* is not in agreement with previous reports in the literature describing low levels of antioxidant activity in the essential oil of *P. auritum*, which was found to contain metabolites such as safrole, myristicin, *D*-germacrene and β-caryophyllene,\[[@ref31]\] or the lack of antioxidant activity of the methanol and aqueous extracts from *P. auritum*.\[[@ref32]\]

CONCLUSIONS {#sec1-4}
===========

The results of this investigation contribute to the knowledge about the biological activity in species that are commonly used to treat diabetes, hypertension, and obesity in the Yucatan peninsula. Additional studies are necessary to identify the metabolites responsible for the biological activity detected in the root extract of *C. fistula* (CFR).
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